[1]
Ayón, C. et al. 2022. Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment. Borneo Journal of Pharmacy. 5, 3 (Aug. 2022), 229–246. DOI:https://doi.org/10.33084/bjop.v5i3.2095.